Despite lagging the broader market over the past year, fertilizer giant Mosaic is showing signs of a rebound in 2026. Analysts maintain a cautiously optimistic 'Moderate Buy' stance, eyeing a potential recovery in crop nutrient demand.
Despite trailing the S&P 500 and tech sector peers over the past year, Super Micro Computer (SMCI) retains a 'Moderate Buy' consensus from Wall Street, with some analysts forecasting significant upside amid ongoing margin pressures and competitive challenges.
Sandra Harris is stepping down as CFO of Genesco, with CEO Mimi Vaughn taking on the role temporarily. The exit comes as the footwear retailer navigates a recent restructuring and revises its sales outlook amid challenging market conditions.
The trial of four men charged with the murder of Michelle Sadio, a mother of two killed outside a Harlesden church in 2024, has begun, revealing allegations of a botched attack targeting a local rapper.
Harrel Braddy, convicted of kidnapping a mother and daughter from their home and leaving the child to die in the Everglades, has been sentenced to life in prison after a jury declined to reinstate the death penalty.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
A broad crypto market sell-off has dragged AI-linked tokens to one of their steepest weekly declines in recent memory, erasing billions in value. Despite the price pain, key infrastructure projects in the decentralized AI and agent ecosystem continue to advance.
The enterprise software firm's unprecedented Bitcoin treasury position fell below its average cost basis over the weekend, marking a rare paper loss event, even as the company continues its aggressive acquisition strategy.
Digital asset investment products have recorded a second straight week of heavy outflows, with U.S.-listed funds leading the sell-off. Analysts point to market jitters over a potential policy shift at the Federal Reserve following a key nomination by President Trump.
Alphabet's planned $13 billion investment in Waymo, valuing the self-driving unit at $110 billion, challenges the long-held view of its moonshot projects as mere financial drains and positions autonomous driving as a core future asset.
Despite a post-earnings slump and near 52-week lows, Abbott Laboratories' resilient medical device unit, strategic expansion in diabetes care, and a landmark acquisition in cancer diagnostics paint a promising long-term picture for this Dividend Aristocrat.
Heightened volatility and extreme fear grip the crypto market, setting the stage for potential mass liquidations in SOL, HYPE, and TRX. Traders on both sides of the fence are bracing for impact.
While Disney's latest earnings surpassed expectations, investor focus shifted sharply to reports of an accelerated CEO succession timeline, sending the stock lower despite robust performance in streaming and theme parks.
Despite a significant lag behind the broader market over the past year, analysts maintain a cautiously optimistic stance on Copart's long-term prospects, even as near-term headwinds persist.
Despite a recent earnings miss, Charles Schwab's stock has significantly outpaced the market over the past year. Wall Street maintains a cautiously optimistic stance, with upgraded ratings and bullish price targets pointing to further potential gains.
As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.
Recent financial disclosures reveal significant repositioning by Speaker Emerita Nancy Pelosi and her husband in tech giants Nvidia, Apple, and Alphabet, sparking investor interest in their strategy of locking in gains while maintaining bullish exposure.
The health retailer unveils its first AI-powered 'Shoppe Advisor' in a Manhattan flagship, aiming to blend digital personalization with human expertise in a competitive market, following a year of ownership changes and executive reshuffling.
Tenet Healthcare has regained complete ownership of its revenue cycle management subsidiary Conifer, buying out CommonSpirit Health's minority stake in a deal valued at nearly $2.7 billion. The move signals Tenet's renewed commitment to the business and plans for significant AI investment.
After years of aggressive rate hikes blamed for stifling manufacturing and squeezing truckers, the nomination of Kevin Warsh to lead the Federal Reserve suggests a pivotal policy shift. This analysis examines the toll of recent monetary policy on the freight sector and what a Warsh-led Fed might mean for its recovery.
